-
Study aim
-
Determining the effectiveness of Integrated Neuromuscular Inhibition Technique on pain, function, grip strength, and muscle activity in patients with lateral epicondylitis.
-
Design
-
Clinical trial includes two groups of intervention and control, one blinded , Randomization in the form of permutation blocks.
-
Settings and conduct
-
This trial will be conducted at Zahedan University of Medical Sciences. Patients are blinded to the treatment. Patients are explained about the study. After obtaining informed consent, randomization will be performed. The initial size of the variables will be recorded. Individuals in each group will receive the treatment three times a week, for 4 continuous weeks, and at the end, the variables are recorded again.
-
Participants/Inclusion and exclusion criteria
-
Inclusion :
Age between 18 to 60 years.
Pain intensity at the initial visit should be at least 3.
Unilateral elbow pain lasting more than 3 months.
Tenderness near or on the lateral epicondyle.
Positive 3 of the following 4 test: Grip strength, Cozen, Mill, Maudsley.
No cardiovascular disease.
No neurological disease.
No neuromuscular disease or nerve entrapment.
No history of trauma to the lateral epicondyle.
No history of previous surgery.
No other treatment in the last 6 months.
Exclusion :
No willingness to receive manual therapy.
Failure to complete treatment sessions.
Exacerbation of symptoms or patient dissatisfaction with the continuation of sessions.
-
Intervention groups
-
1- Intervention group: In addition to routine treatment, also receives Integrated Neuromuscular Inhibition Technique(INIT); it includes several manual treatments (ischemic pressure, strain-counterstrain, and muscle energy technique).
2- Control group: only received routine physiotherapy treatments; included: hot pack, TENS, ultrasound, education and exercises.
-
Main outcome variables
-
Pain; Disability; Grip strength; Muscle activity.